HCA Healthcare, Inc. - HCA STOCK NEWS

HCA Healthcare, Inc. reported robust financial results for Q4 2020, with revenues of $14.293 billion, a rise from $13.523 billion in Q4 2019. Net income surged to $1.426 billion, or $4.13 per diluted share, up from $1.071 billion or $3.09 per share a year prior. Adjusted EBITDA reached $3.118 billion. However, same facility admissions and emergency room visits declined 3.4% and 21% respectively. The company announced the resumption of its share repurchase program and declared a quarterly dividend of $0.48 per share, payable on March 31, 2021, while providing 2021 revenue guidance of $53.5 to $55.5 billion.

HCA Healthcare (NYSE:HCA) has formed a consortium, including several prestigious research institutions, to utilize its extensive data on COVID-19 hospital care aimed at enhancing patient outcomes. The consortium, named COVID-19 CHARGE, will enable members to conduct studies on treatment efficacy and safety, leveraging HCA's repository of over 110,000 COVID-19 inpatient admissions from 2020. This partnership is expected to contribute valuable insights into COVID-19 care, potentially leading to new clinical trials that could save lives.

HCA Healthcare has formed a joint venture with A Plus International Inc. to produce surgical masks domestically, addressing the rising demand for PPE. The manufacturing facility in Asheville, North Carolina, will begin production in early 2021, funded equally by both companies. HCA's investment stems from its Mission Fund, created to support healthcare businesses in Western North Carolina. This initiative aims to enhance the supply chain for healthcare providers and create skilled jobs in the area.

HCA Healthcare, Inc. (NYSE: HCA) has scheduled its 4Q Earnings Release Call on Tuesday, February 2, 2021, at 9:00 AM Central (10:00 AM Eastern). The event will be available via live audio streaming on their investor relations website. For those unable to attend live, the call will be archived for later access. This call is anticipated to provide critical insights regarding the company's financial performance, including earnings, revenue, and future outlook.

HCA Healthcare collected 13,523 pounds of unused and expired prescription medications during its "Crush the Crisis" opioid take back day on October 24, 2020, more than double last year's amount. Events were held at 95 facilities across 18 states, aligned with the DEA’s National Prescription Drug Take Back Day, aiming to combat opioid misuse. This initiative disposed of around 9.3 million doses of medication, addressing an escalating opioid crisis marked by rising mortality in 40 states. The movement emphasizes community awareness and safe disposal of medications.

HCA Healthcare has appointed Mitch Edgeworth as the new president of its TriStar Division, effective January 4, 2021. He takes over from Heather Rohan, who is retiring after a 34-year career with the company. Edgeworth, a veteran with 23 years in the healthcare sector, was previously the chief administrative officer of the TriStar Division and has held leadership roles at Vanderbilt University Medical Center and Quorum Health Resources. He will oversee 17 hospitals across Tennessee, Georgia, and Kentucky.

HCA Healthcare (NYSE: HCA) will join two virtual conferences in November 2020. The first take place on November 10 at 10:15 a.m. (EST) during the Credit Suisse 29th Annual Virtual Healthcare Conference. The second is scheduled for November 19 at the 2nd Annual Wolfe Healthcare Conference, which will consist of investor meetings only and no public presentation. Interested parties can find audio webcasts and presentation materials on the Investor Relations section of HCA's website. Schedules may change, so check for updates regularly.

HCA Healthcare reported its Q3 2020 financial results, showing revenues of $13.311 billion, a 4.9% increase from $12.694 billion in Q3 2019. Net income rose to $668 million, or $1.95 per diluted share, up from $612 million, or $1.76 per diluted share, the previous year. However, the company reversed $822 million in CARES Act stimulus funds, impacting adjusted EBITDA, which fell to $2.053 billion from $2.285 billion in Q3 2019.

Same facility admissions decreased by 3.8%, with emergency room visits down 20.3%. Cash flows from operations reached $2.717 billion, reflecting a solid operational performance.

HCA Healthcare, Inc. (NYSE: HCA) has scheduled its 3Q Earnings Release Call for October 26, 2020, at 9:00 AM Central Time. The call will be streamed live over the internet, allowing investors and analysts to gain insights into the company’s financial performance. For those unable to attend, an archived version will be available on their website following the event. This earnings call is crucial for stakeholders looking to understand HCA's revenue trends, earnings per share, and overall financial health in the current economic landscape.